The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots.

Novavax Inc. (NVAX) shares jumped 15% after the company received a long-awaited U.S. FDA approval for its COVID-19 vaccine. Shares of Regeneron Pharmaceuticals, Inc. (REGN) rose 0.4% after deciding to ...

The U.S. Food and Drug Administration (FDA) announced new regulatory guidelines for COVID-19 vaccine boosters on Tuesday, ...

Over the past weekend, the new CEO of UnitedHealth (UNH) bought shares after the sell-off. UNH stock gained 8.21% to close at ...

The U.S. Food and Drug Administration (FDA ) leaders said on Tuesday they would adopt a new COVID-19 vaccination regulatory ...

Shares of vaccine makers saw an uptick in the latest trading session, with Moderna Inc (BMV:MRNA). (NASDAQ:MRNA) leading the ...

U.S. stock futures were slightly lower on Tuesday after ending largely flat on Monday. Futures of major benchmark indices ...

GAITHERSBURG, MD, USA I May 19, 2025 I Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved the ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...